Belite Bio’s Stock Surge: Volatility, Low Liquidity and Questionable Momentum
Investors see a volatile surge in Belite Bio (BLTE) as the stock defies fundamentals—yet shallow liquidity and a lack of approved drugs warn of a speculative bubble.
3 minutes to read